SAN FRANCISCO, CA – (March 11, 2026) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Driven Brands Holdings, Inc. (“Driven Brands” or the “Company”) (NASDAQ: DRVN) who purchased or otherwise acquired the common stock of Driven Brands between May 9, 2023 and February 24, 2026, inclusive (the “Class Period”)
SAN FRANCISCO, CA – (March 4 2026) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD) who purchased or otherwise acquired the publicly traded securities of Kyndryl between August 7, 2024 and February 9, 2026, inclusive (the “Class Period”) to contact
SAN FRANCISCO, CA – (December 21, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in National Instruments Corporation (“National Instruments” or “NATI” or the “Company”) (NASDAQ: NATI) who suffered losses from selling NATI common stock between May 25, 2022 and January 17, 2023 to contact us immediately regarding a
SAN FRANCISCO, CA – (December 14, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Dollar General Corporation (“Dollar General” or the “Company”) (NYSE: DG) who suffered losses from purchasing or otherwise acquiring the securities of Dollar General between May 28, 2020 and August 31, 2023 to contact us
SAN FRANCISCO, CA – (December 11, 2023) – National plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in FMC Corporation (“FMC” or the “Company”) (NYSE: FMC) who suffered losses from purchasing or otherwise acquiring FMC common stock between February 9, 2022 and October 30, 2023 to contact us immediately regarding a pending
SAN FRANCISCO, CA – (November 9, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in DocGo Inc. (“DocGo” or the “Company”) (Nasdaq: DCGO) who suffered losses from purchasing or otherwise acquiring the securities of DocGo between November 8, 2022 and September 17, 2023 to contact us immediately regarding a